Fonar (FONR) Earns Daily News Impact Rating of 0.25

Media coverage about Fonar (NASDAQ:FONR) has trended positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Fonar earned a media sentiment score of 0.25 on Accern’s scale. Accern also gave press coverage about the medical equipment provider an impact score of 48.0434255092302 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Shares of Fonar stock traded down $0.40 during trading on Friday, reaching $27.60. The company’s stock had a trading volume of 35,283 shares, compared to its average volume of 33,284. The stock has a market capitalization of $173.54, a price-to-earnings ratio of 9.23 and a beta of 2.07. Fonar has a fifty-two week low of $17.20 and a fifty-two week high of $33.90.

How to Become a New Pot Stock Millionaire

Fonar (NASDAQ:FONR) last announced its earnings results on Monday, February 12th. The medical equipment provider reported $0.70 EPS for the quarter. The business had revenue of $20.17 million for the quarter. Fonar had a net margin of 23.44% and a return on equity of 23.26%.

In other news, Director Robert J. Janoff sold 1,000 shares of Fonar stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $25.73, for a total value of $25,730.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 8.33% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Fonar (FONR) Earns Daily News Impact Rating of 0.25” was first reported by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/3341466/fonar-fonr-earns-daily-news-impact-rating-of-0-25.html.

About Fonar

Fonar Corporation, together with its subsidiaries, engages in the design, manufacture, sale, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, and other medical conditions and injuries. It operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.

Insider Buying and Selling by Quarter for Fonar (NASDAQ:FONR)

Receive News & Ratings for Fonar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fonar and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks Investment Research Upgrades News  to Buy
Zacks Investment Research Upgrades News to Buy
Hospital Co. of America  Upgraded to Buy by Zacks Investment Research
Hospital Co. of America Upgraded to Buy by Zacks Investment Research
Commerce Bancshares  Upgraded by Zacks Investment Research to “Buy”
Commerce Bancshares Upgraded by Zacks Investment Research to “Buy”
The Bank of New York Mellon’s  “Hold” Rating Reaffirmed at Sandler O’Neill
The Bank of New York Mellon’s “Hold” Rating Reaffirmed at Sandler O’Neill
Ares Management  Given Coverage Optimism Score of 0.06
Ares Management Given Coverage Optimism Score of 0.06
Orion Engineered Carbons  Given Daily News Sentiment Rating of 0.08
Orion Engineered Carbons Given Daily News Sentiment Rating of 0.08


Leave a Reply

© 2006-2018 Ticker Report. Google+.